UZ Leuven - Centrum voor Moleculaire en Vasculaire Biologie
Leuven 3000
1 studies enrolling now · 1 studies all time
What they study most
Hemophilia B
Studies at this site
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
— Recruiting now